Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine

Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine

Εμφάνιση άλλων εκδόσεων (1)

Background: Bactericidal antibody induced by immunization of infants with serogroup C Neisseria meningitidis (MenC) vaccines wanes rapidly during childhood. Adolescents are at particular risk from meningococcal disease, therefore they might benefit from a booster dose of vaccine. The duration of ser...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	De Whalley, P, Snape, MD, Kelly, D, Banner, C, Lewis, S, Diggle, L, John, T, Yu, L, Omar, O, Borkowski, A, Pollard, A
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2011

Παρόμοια τεκμήρια

Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine.
ανά: de Whalley, P, κ.ά.
Έκδοση: (2011)

Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
ανά: Snape, MD, κ.ά.
Έκδοση: (2006)

Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
ανά: Snape, M, κ.ά.
Έκδοση: (2006)

Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
ανά: Snape, MD, κ.ά.
Έκδοση: (2009)

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
ανά: Micoli, F, κ.ά.
Έκδοση: (2013)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
ανά: Sachin Shivatare, κ.ά.
Έκδοση: (2022-08-01)

Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
ανά: Khatami, A, κ.ά.
Έκδοση: (2011)

Towards an improved serogroup B Neisseria meningitidis vaccine.
ανά: Perrett, K, κ.ά.
Έκδοση: (2005)

The development of an experimental multiple serogroups vaccine for Neisseria meningitidis.
ανά: Valerian B Pinto, κ.ά.
Έκδοση: (2013-01-01)

A vaccine against serogroup B Neisseria meningitidis: Dealing with uncertainty
ανά: Andrews, S, κ.ά.
Έκδοση: (2014)

A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty.
ανά: Andrews, S, κ.ά.
Έκδοση: (2014)

Recent advances in lipopolysaccharide-based glycoconjugate vaccines
ανά: Zhu, H, κ.ά.
Έκδοση: (2021)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
ανά: Giuseppe Stefanetti, κ.ά.
Έκδοση: (2022-09-01)

Carriers and Antigens: New Developments in Glycoconjugate Vaccines
ανά: Robert M.F. van der Put, κ.ά.
Έκδοση: (2023-01-01)

Glycoconjugate vaccines against antimicrobial resistant pathogens
ανά: Charlotte Sorieul, κ.ά.
Έκδοση: (2023-12-01)

Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development
ανά: Cinzia Colombo, κ.ά.
Έκδοση: (2018-07-01)

Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness
ανά: Ray Borrow, κ.ά.
Έκδοση: (2023-12-01)

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
ανά: Perrett, K, κ.ά.
Έκδοση: (2009)

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
ανά: Pace, D, κ.ά.
Έκδοση: (2016)

Recombinant production platform for Group A Streptococcus glycoconjugate vaccines
ανά: Sowmya Ajay Castro, κ.ά.
Έκδοση: (2025-01-01)

Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.
ανά: Sara Tartof, κ.ά.
Έκδοση: (2013-01-01)

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
ανά: Snape, MD, κ.ά.
Έκδοση: (2008)

Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.
ανά: Khatami, A, κ.ά.
Έκδοση: (2012)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
ανά: Snape, MD, κ.ά.
Έκδοση: (2013)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
ανά: Snape, M, κ.ά.
Έκδοση: (2013)

Progress towards a glycoconjugate vaccine against Group A Streptococcus
ανά: Keira Burns, κ.ά.
Έκδοση: (2023-03-01)

Correction: Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt.
ανά: Sara Tartof, κ.ά.
Έκδοση: (2017-01-01)

Will booster doses be required for serogroup B meningococcal vaccine?
ανά: McQuaid, F, κ.ά.
Έκδοση: (2014)

Fatal meningococcemia due to Neisseria meningitidis serogroup Y in a vaccinated child receiving eculizumab
ανά: Meltem Polat, κ.ά.
Έκδοση: (2018-11-01)

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial
ανά: Pace, D, κ.ά.
Έκδοση: (2008)

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.
ανά: Pace, D, κ.ά.
Έκδοση: (2008)

Recent advances in the biosynthesis of polysaccharide-based antimicrobial glycoconjugate vaccines
ανά: Yuhui Wang, κ.ά.
Έκδοση: (2025-01-01)

Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
ανά: Victor Morais, κ.ά.
Έκδοση: (2022-12-01)

Site-Specific Conjugation for Fully Controlled Glycoconjugate Vaccine Preparation
ανά: Aline Pillot, κ.ά.
Έκδοση: (2019-11-01)

Improving Chicken Responses to Glycoconjugate Vaccination Against Campylobacter jejuni
ανά: Harald Nothaft, κ.ά.
Έκδοση: (2021-11-01)

Serogroup A Neisseria meningitidis with Reduced Susceptibility to Ciprofloxacin
ανά: Jacob Strahilevitz, κ.ά.
Έκδοση: (2008-10-01)

Neisseria meningitidis Strain of Unknown Serogroup, China
ανά: Haijian Zhou, κ.ά.
Έκδοση: (2011-03-01)

Neisseria meningitidis Serogroup W135, China
ανά: Zhujun Shao, κ.ά.
Έκδοση: (2010-02-01)

Recent developments in glycoconjugates
ανά: Davis, B
Έκδοση: (1999)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
ανά: Read, R, κ.ά.
Έκδοση: (2014)